JPH0514227B2 - - Google Patents
Info
- Publication number
- JPH0514227B2 JPH0514227B2 JP57135487A JP13548782A JPH0514227B2 JP H0514227 B2 JPH0514227 B2 JP H0514227B2 JP 57135487 A JP57135487 A JP 57135487A JP 13548782 A JP13548782 A JP 13548782A JP H0514227 B2 JPH0514227 B2 JP H0514227B2
- Authority
- JP
- Japan
- Prior art keywords
- sample
- reagent
- enzyme
- layer
- reagent layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims description 78
- 102000004190 Enzymes Human genes 0.000 claims description 51
- 108090000790 Enzymes Proteins 0.000 claims description 51
- 239000000758 substrate Substances 0.000 claims description 49
- 238000012360 testing method Methods 0.000 claims description 23
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 230000007480 spreading Effects 0.000 claims description 11
- 238000003892 spreading Methods 0.000 claims description 11
- 239000007795 chemical reaction product Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 239000003094 microcapsule Substances 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 4
- 230000024203 complement activation Effects 0.000 claims description 3
- 230000002101 lytic effect Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 47
- 238000006243 chemical reaction Methods 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 210000003743 erythrocyte Anatomy 0.000 description 16
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 210000000170 cell membrane Anatomy 0.000 description 10
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 9
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 238000003018 immunoassay Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 6
- 102100022624 Glucoamylase Human genes 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229920000936 Agarose Polymers 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 239000000644 isotonic solution Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108010015776 Glucose oxidase Proteins 0.000 description 4
- 239000004366 Glucose oxidase Substances 0.000 description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 229940116332 glucose oxidase Drugs 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 229920000856 Amylose Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000004357 Transferases Human genes 0.000 description 3
- 108090000992 Transferases Proteins 0.000 description 3
- 238000001311 chemical methods and process Methods 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 102000004641 Fetal Proteins Human genes 0.000 description 2
- 108010003471 Fetal Proteins Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000001461 cytolytic effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- LJCNDNBULVLKSG-UHFFFAOYSA-N 2-aminoacetic acid;butane Chemical compound CCCC.CCCC.NCC(O)=O LJCNDNBULVLKSG-UHFFFAOYSA-N 0.000 description 1
- 102000034279 3-hydroxybutyrate dehydrogenases Human genes 0.000 description 1
- 108090000124 3-hydroxybutyrate dehydrogenases Proteins 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
- 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 102000002281 Adenylate kinase Human genes 0.000 description 1
- 108020000543 Adenylate kinase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010041525 Alanine racemase Proteins 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 description 1
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010089254 Cholesterol oxidase Proteins 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 108010077078 Creatinase Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 108010015133 Galactose oxidase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108700016167 Glutamate racemases Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FORGMRSGVSYZQR-YFKPBYRVSA-N L-leucinamide Chemical compound CC(C)C[C@H](N)C(N)=O FORGMRSGVSYZQR-YFKPBYRVSA-N 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010063372 N-Glycosyl Hydrolases Proteins 0.000 description 1
- 102000010722 N-Glycosyl Hydrolases Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010063734 Oxalate oxidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- 108010042687 Pyruvate Oxidase Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 108091022873 acetoacetate decarboxylase Proteins 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RNBGYGVWRKECFJ-ARQDHWQXSA-N beta-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ARQDHWQXSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940045189 glucose-6-phosphate Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- LLZRNZOLAXHGLL-UHFFFAOYSA-J titanic acid Chemical compound O[Ti](O)(O)O LLZRNZOLAXHGLL-UHFFFAOYSA-J 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãçºæã®æè¡åéã
ãã®çºæã¯ãçäœããæ¡åããè©Šæäžã®åçš®ã®
æåã枬å®ããèšåºæ€æ»è£
眮ã®æè¡åéã«å±ã
ããDETAILED DESCRIPTION OF THE INVENTION [Technical Field of the Invention] The present invention belongs to the technical field of clinical testing devices that measure various components in samples collected from living organisms.
èšåºååŠåæã®äžææ³ã«ãã©ã€ã±ãã¹ããªãŒæ³
ãããããã©ã€ã±ãã¹ããªãŒæ³ã¯ãè©Šè¬ããã¿èŸŒ
ãŸããçŽãããã¯è©Šè¬ãå¡åžãã也ç¥ç¶æ
ã®ã
ã€ã«ã ã«è©Šæã滎äžããè©Šè¬ãšè©Šæãšã®åå¿åŸã
è©Šæã滎äžãããã€ã«ã éšåãŸãã¯çŽéšåã«çº
è²è©Šè¬ãäœçšãããŠåè²ãããã®åžå
床ã枬å®ã
ãããšã«ããè©Šæäžã®æåãåæãããã®ã§ã
ãã
One method of clinical chemical analysis is the dry chemistry method. In the dry chemistry method, a sample is dropped onto paper impregnated with a reagent or a dry film coated with the reagent, and after the reagent and sample react,
A coloring reagent is applied to the film or paper portion onto which the sample has been dropped to develop a color, and the components in the sample are analyzed by measuring the absorbance.
ããããªããããã®ãã©ã€ã±ãã¹ããªãŒæ³ã¯ã
è©Šè¬ãšè©Šæãšã®åå¿åŸã«ãåå¿éšåãçºè²ããã
ããã®çºè²æ©æ§ãå¿
èŠã§ããããŸããåè²éšåã«
ãããç¹å®ã®æ³¢é·ãæ€åºããããã«ããã¯ã°ã©ãŠ
ã³ããæå¶ããªããã°ãªããªãããåžå
床枬å®ã®
ããã«å
åŠç³»ãå¿
èŠãšããããè£
眮ãè€éåãã
ãšããåé¡ç¹ãããã However, this dry chemistry method
After the reaction between the reagent and the sample, a coloring mechanism is required to develop color in the reaction area, and the background must be suppressed in order to detect a specific wavelength in the colored area, and the background must be suppressed to detect the specific wavelength in the colored area. There is a problem in that the device becomes complicated because it requires an optical system.
ãŸããèšåºååŠåæã«ãããŠãé
µçŽ ãå¿çšãã
åææ³ãšããŠãé
µçŽ ã溶液ç¶æ
ã§çšãã溶液æ³ãš
é
µçŽ ãäžæº¶æ§æ
äœã«çµåããŠãããå埩å©çšãã
åºå®åé
µçŽ æ³ãšãããã In addition, in clinical chemistry analysis, as analytical methods that apply enzymes, there are a solution method in which the enzyme is used in a solution state and an immobilized enzyme method in which the enzyme is bound to an insoluble carrier and used repeatedly.
ããããªãããåèšæº¶æ¶²æ³ã«ã¯é
µçŽ ã®å¯¿åœãç
ããšããæ¬ ç¹ããããåèšåºå®åé
µçŽ æ³ã¯ãåœå
ã«æåŸ
ãããŠããã»ã©ã®çµæžçã¡ãªããããªãäž
ã«ãé
µçŽ 寿åœãåèšæº¶æ¶²æ³ã®å Žåãããé·ããã
ãã§ãäžå
åã§ãããšããæ¬ ç¹ãããã However, the solution method has the disadvantage of a short enzyme life, and the immobilized enzyme method does not have as much economic merit as originally expected, and the enzyme life is shorter than that of the solution method. Although it is long, it still has the drawback of being insufficient.
ããã«ãèšåºååŠåæã«ãããŠãå
ç«åææ¹æ³
ãšããŠãã©ãžãªã€ã ãã¢ãã»ã€æ³ããšã³ã¶ã€ã ã€
ã ãã¢ãã»ã€æ³ãããããããããååãªæ€åºã
å¯èœãšãªããŸã§ã«æ°æéããæ°10æéãã®é·æé
ãèŠãããšããæ¬ ç¹ãããã Furthermore, in clinical chemistry analysis, immunoassay methods include radioimmunoassay and enzyme immunoassay, but both require a long time, ranging from several hours to several tens of hours, before sufficient detection is possible. There are drawbacks.
ãã®çºæã¯åèšäºæ
ã«éã¿ãŠãªããããã®ã§ã
ãã液ç¶è©Šæäžã®ç¹å®ç©è³ªãç°¡æãã€è¿
éã«å®é
ããããšã®ã§ãããç°¡åãªæ§æã®æ€äœæ€æ»ãŠãã
ããæäŸããããšãç®çãšãããã®ã§ããã
The present invention has been made in view of the above circumstances, and it is an object of the present invention to provide a sample testing unit with a simple configuration that can easily and quickly quantify a specific substance in a liquid sample.
åèšç®çãéæããããã®æ¬çºæã«ä¿ãæ€äœæ€
æ»ãŠãããã¯ãè©Šè¬ãåºå®åä¿æãããè©Šè¬å±€
ãšãã²ã«ã«ããæ§æããããšå
±ã«åèšè©Šè¬å±€äžã«
éç³ããè©Šæãåäžãªæ¿åºŠã§æ¡æ£ããŠåèšè©Šè¬å±€
ã«ç§»éããå±éå±€ãšãå±éå±€ããæ¡æ£ããŠããè©Š
æãšè©Šè¬å±€äžã®è©Šè¬ãšã®åå¿çæç©ãé»æ°ååŠç
ã«æ€åºããæ€åºæ段ãšãæããåèšå±éå±€ã«è©Šæ
ã滎äžããããšã«ãã該詊æã®æåãé»æ°ååŠç
ã«æž¬å®ãããã®ã§ããã
The specimen testing unit according to the present invention for achieving the above object is composed of a reagent layer in which a reagent is immobilized and held, and a gel, which is superimposed on the reagent layer and diffuses the sample at a uniform concentration. The method includes a developing layer that is transferred to the reagent layer, and a detection means that electrochemically detects a reaction product between the sample diffused from the developing layer and the reagent in the reagent layer, and dropping the sample onto the developing layer. The components of the sample are measured electrochemically.
ãã®çºæã®äžå®æœäŸè£
眮ã«ã€ããŠãå³é¢ãåç
§
ããªãã説æããã第ïŒå³ã¯ããã®çºæã®äžå®æœ
äŸè£
眮ã瀺ã説æå³ã§ããã
An embodiment of the present invention will be described with reference to the drawings. FIG. 1 is an explanatory diagram showing an apparatus according to an embodiment of the present invention.
第ïŒå³ã«ãããŠãïŒã§ç€ºãã®ã¯ãè©Šè¬ãæ
äœã«
ä¿æããŠãªãè©Šè¬å±€ã§ãããäžè¯å°é»äœãããªã
åå¿ãŠãããåºæ¿ïŒäžã«åœ¢æãããŠãããè©Šè¬å±€
ïŒã®äžé¢ã«ã¯ãå¿
èŠã«å¿ããŠèšããããåéèç
ã®éèïŒãä»ããŠãæå®æ¿åºŠã®è©Šæãåäžã«å±é
ããå±éå±€ïŒãéç³ãããŠãããåå¿ãŠãããåº
æ¿ïŒã®ããšãã°äžå€®éšã«ã¯é»æ¥µæ¿å
¥åïŒãéå£ã
ãŠããããã®é»æ¥µæ¿å
¥åïŒã«é»æ¥µéšïŒãè£
çãã
ããšãã§ããããã«ãªã€ãŠãããé»æ¥µéšïŒãé»æ¥µ
æ¿å
¥åïŒã«è£
çãããšé»æ¥µéšïŒããçªåºããé»æ¥µ
ãåèšè©Šè¬å±€ïŒã«æ¿å
¥ãããããšãšãªããè©Šè¬å±€
ïŒã§çããåå¿ã®çæç©ãé»åååŠçã«æ€åºãã
ããšãã§ããããã«ãªã€ãŠãããé»æ¥µéšïŒããåŒ
ãåºããããªãŒãç·ïŒã¯ã¢ã³ãïŒã«æ¥ç¶ãããŠã
ãŠãé»æ¥µéšïŒããåºåãããæ€åºé»æµãå¢å¹
ãã
ããã«æ§æãããŠãããæ€åºé»æµã¯ãããã«ä¿¡å·
ã±ãŒãã«ïŒãä»ããŠæŒç®éšïŒïŒã«åºåãããæŒç®
éšïŒïŒã«ãããŠè©Šæäžã®ç¹å®æåæ¿åºŠãç®åºãã
ãããã«ãªã€ãŠããã In FIG. 1, 3 is a reagent layer formed by holding a reagent on a carrier, and is formed on a reaction unit substrate 4 made of a poor conductor. On the upper surface of the reagent layer 3, a spreading layer 1 for uniformly spreading a sample of a predetermined concentration is superimposed via a diaphragm 2 such as a semipermeable membrane provided as necessary. An electrode insertion hole 5 is opened, for example, in the center of the reaction unit substrate 4, and an electrode part 6 can be attached to the electrode insertion hole 5. When the electrode part 6 is attached to the electrode insertion hole 5, the electrode protruding from the electrode part 6 is inserted into the reagent layer 3, so that the reaction products generated in the reagent layer 3 can be electrochemically detected. It's getting old. A lead wire 7 drawn out from the electrode section 6 is connected to an amplifier 8, and is configured to amplify the detection current output from the electrode section 6. The detected current is further output to a calculation unit 10 via a signal cable 9, and the calculation unit 10 calculates the concentration of a specific component in the sample.
åèšæ€äœæ€æ»ãŠãããã«ã€ããŠããã«è©³è¿°ã
ãã The sample testing unit will be described in further detail.
è©Šè¬å±€ïŒããã³å±éå±€ïŒçã¯ãåæãã¹ãè©Šæ
ã«å¿ããŠæ¬¡ã®ããã«æ§æããããšãã§ããã The reagent layer 3, development layer 1, etc. can be configured as follows depending on the sample to be analyzed.
è©Šæäžã®åºè³ªæåãŸãã¯é
µçŽ æåãåèšæ€äœæ€
æ»ãŠãããã§åæããå Žåã«ã€ããŠè¿°ã¹ãã A case will be described in which a substrate component or an enzyme component in a sample is analyzed using the sample testing unit.
è©Šè¬å±€ïŒäžã®æ
äœã¯ãé
µçŽ ãŸãã¯åºè³ªãç©çç
åžçãååŠççµåã«ããä¿æãããããã¯åºå®å
ããããšãã§ããã°ã©ã®ããã§ãã€ãŠããããã
ãšãã°ãããªã¢ã¯ãªã«ã¢ãããããªãŠã¬ã¿ã³ãã
ãªããã«ã¢ã«ã³ãŒã«ãããªããã«ãããªãã³çã®
ãããªæ¥µæ§åºãæããåæé«ååã®ã²ã«ãã¢ã¬ã
ãŒã¹çã®å€ç³é¡ã®ã²ã«ãã³ã©ãŒã²ã³ããŒã©ãã³ç
ã®èçœè³ªã®ã²ã«ãæ°Žé
žåã¢ã«ãããŠã ãæ°Žé
žåã
ã¿ã³çã®éå±æ°Žé
žåç©ã®ã²ã«ãã€ãªã³äº€ææš¹èã
è¡šé¢åŠçã«ããè¡šé¢ã«ã¢ããåºçã®æ¥µæ§åºãæ
ãããŸãã¯æããªãå€åæ§ã¬ã©ã¹ããŒãºããã©ã¹
ããã¯èããŒãªã©ã€ããã¢ã³ã¢ãªããã€ãçã®ã
ããªã¯ã¬ã€çã®çµåæ¯æäœãæãããããããã
æ
äœã«é
µçŽ ãŸãã¯åºè³ªãç©ççåžçãããã¯ååŠ
ççµåã«ããå
æ¬ããããããã¯åºå®åãããã The carrier in the reagent layer 3 may be any carrier as long as it can hold or immobilize the enzyme or substrate through physical adsorption or chemical bonding, such as polyacrylamide, polyurethane, polyvinyl alcohol, polyvinylpyrrolidone. Gels of synthetic polymers with polar groups such as, gels of polysaccharides such as agarose, gels of proteins such as collagen and gelatin, gels of metal hydroxides such as aluminum hydroxide and titanium hydroxide, and ion exchange resins. ,
Examples include bonded supports such as porous glass beads, plastic membranes, zeolites, clays such as montmorillonite, etc., which may or may not have polar groups such as amide groups on their surfaces due to surface treatment. Enzymes or substrates are entrapped or immobilized on these carriers by physical adsorption or chemical bonding.
è©Šè¬å±€ïŒäžã®è©Šè¬ãšããŠã¯ãè©Šæäžã®åºè³ªæå
ãåæããå Žåãè©Šæäžã®åºè³ªãšç¹ç°çã«é
µçŽ å
å¿ãããšå
±ã«ãã®é
µçŽ åå¿çæç©ãé»æ°ååŠçã«
åæå¯èœãªé
µçŽ ãããã¯ãã®ãããªé
µçŽ ãå«æã
ã埮çç©ãæãããããåèšé
µçŽ ãšããŠãé
žåé
å
é
µçŽ ããšãã°ããããé
žãªãã·ããŒãŒããã«ã
ã³é
žãªãã·ããŒãŒãä¹³é
žãªãã·ããŒãŒãâã¢ã
ãé
žãªãã·ããŒãŒãâã¢ããé
žãªãã·ããŒãŒã
ã¢ãã¢ãã³ãªãã·ããŒãŒãã°ã«ã³ãŒã¹ãªãã·ããŒ
ãŒãããµã³ãã³ãªãã·ããŒãŒããžã¢ãã³ãªãã·ã
ãŒãŒãã¢ã«ã³ãŒã«ãªãã·ããŒãŒããŠãªã«ãŒãŒãã¬
ã©ã¯ããŒã¹ãªãã·ããŒãŒãã¢ã·ã«ã³ãšã³ã¶ã€ã 
ãªãã·ããŒãŒãã³ã¬ã¹ãããŒã«ãªãã·ããŒãŒãã¶
ã«ã³ã·ã³ãªãã·ããŒãŒãããŒãªãã·ããŒãŒãã«ã¿
ã©ãŒãŒãä¹³é
žè±æ°ŽçŽ é
µçŽ ïŒLDHïŒãã°ãªã»ããŒã«
âïŒâãªã³é
žããããã²ããŒãŒãïŒâããããã·
é
ªé
žããããã²ããŒãŒã3αã¹ããã€ããããã
ã²ããŒãŒãã°ãªã³ãŒã¹âïŒâãªã³é
žããããã²ã
ãŒãŒãã°ã«ã³ãŒã¹ããããã²ããŒãŒããã¬ãŒãã
ãããã²ããŒãŒãã€ãœã¯ãšã³é
žããããã²ããŒ
ãŒãå æ°Žå解é
µçŽ ããšãã°ãã°ã«ã¿ãã³é
žãã«ã«
ããã·ã©ãŒãŒãã¢ã¹ãã«ã¿ãŒãŒãã¢ããã·ã³ãã¢
ãããŒãŒããã¯ã¬ãªã·ããŒãŒãã·ãã·ã³ãã¢ãã
ãŒãŒãã¯ã¬ã¢ãã³ã»ã¢ããžããããã©ãŒãŒããŠã¬
ã¢ãŒãŒãã¢ã»ãé
¢é
žãã«ã«ããã·ã©ãŒãŒãã¢ã«ã«
ãªãã¹ãã¢ã¿ãŒãŒãé
žæ§ãã¹ãã¢ã¿ãŒãŒããã«ã
ã³é
žãã«ã«ããã·ã©ãŒãŒããŠããããŒãŒããã¹ã
ãªããŒãŒïŒ£ããªããŒãŒãã«ã«ããã·ãããããŒ
ãŒããã€ã·ã³ã¢ãããããããŒãŒãã¢ãã©ãŒãŒã
ã³ãªã³ãšã¹ãã©ãŒãŒãã¢ã«ãã©ãŒãŒããã©ã¹ã
ã³ãããªãã·ã³ããªããã¯ã¬ã¢ãŒãŒãããªãã·ãª
ããã¯ã¬ã¢ãŒãŒããããã¢ãŒãŒãã°ã«ã³ã¢ãã©ãŒ
ãŒã転移é
µçŽ ããšãã°ããã«ãã³é
žãããŒãŒãã
ãªãããŒãŒãã¢ã·ã«ã³ãšã³ã¶ã€ã ã·ã³ã»ã¿ãŒ
ãŒããªã«ããã³ã«ã«ããã«ãã©ã³ã¹ããšã©ãŒãŒã
ã¯ã¬ã¢ãã³ãããŒãŒãã¢ã¹ãã©ã®ã³é
žã¢ãããã©
ã³ã¹ããšã©ãŒãŒãã¢ã©ãã³ã¢ãããã©ã³ã¹ããšã©
ãŒãŒãç°æ§åé
µçŽ ããšãã°ãã°ã«ã¿ãã³é
žã©ã»ã
ãŒãŒãã¢ã©ãã³ã©ã»ããŒãŒãããªãªãŒã¹ãªã³é
žã€
ãœã¡ã©ãŒãŒãçãæããããããŸããè©Šè¬å±€ïŒäž
ã®è©Šè¬ãšããŠãè©Šæäžã®é
µçŽ æåãåæããå Ž
åãåè¿°ã®é
µçŽ ãšç¹ç°çã«é
µçŽ åå¿ãããåºè³ªã
ãšãã°ïŒ¬âã¢ã¹ãã©ã®ã³é
žãâã¢ã©ãã³ãαâ
ã±ãã°ã«ã¿ãŒã«é
žããã«ãã³é
žãâä¹³é
žãâ
ãã€ã·ã³ã¢ãããã°ã«ã³ãŒã¹âïŒâãªã³é
žã柱
ç²ãã¢ã»ãã«ã³ãªã³ãã¯ã¬ã¢ãã³ãã°ã«ã¿ããª
ã³ããšã¿ããŒã«ã¢ãã³ãβâããããã·é
ªé
žããª
ã«ããã³ããã©ã¯ããŒã¹ãã¹ãã¹ããšãŒããããª
ã°ãªã»ãªãããã¹ããªãšããŒã«ãã«ãã³é
žãã€ãœ
ã¯ãšã³é
žããããé
žããã©ã¹ãããŒã²ã³ãããŒã
ãã³ãã¢ã¹ã³ã«ãã³é
žãèçœè³ªãããªãã¯ã¬ãªã
ãçãæããããã When analyzing a substrate component in a sample, the reagent in the reagent layer 3 is an enzyme that specifically enzymatically reacts with the substrate in the sample and can electrochemically analyze the enzymatic reaction product, or such an enzyme. Examples include microorganisms containing. The enzymes include oxidoreductases such as oxalate oxidase, pyruvate oxidase, lactate oxidase, D-amino acid oxidase, L-amino acid oxidase,
Monoamine oxidase, glucose oxidase, xanthine oxidase, diamine oxidase, alcohol oxidase, uricase, galactose oxidase, acyl coenzyme A
Oxidase, cholesterol oxidase, sarcosine oxidase, peroxidase, catalase, lactate dehydrogenase (LDH), glycerol-3-phosphate dehydrogenase, 3-hydroxybutyrate dehydrogenase, 3α steroid dehydrogenase, glycose-6-phosphate dehydrogenase, glucose dehydrogenase , malate dehydrogenase, isocitrate dehydrogenase, hydrolytic enzymes such as glutamate decarboxylase, aspartase, adenosine deaminase, nucleosidase, cytosine deaminase, creatine amidinohydrolase, urease, acetoacetate decarboxylase, alkaline phosphatase, acid phosphatase, Pyruvate decarboxylase, urokinase, phospholipase C, lipase, carboxypeptidase, leucine aminopeptidase, amylase,
Cholinesterase, aldolase, plasmin, trypsin, ribonuclease, deoxyribonuclease, protease, glucoamylase, transferase such as pyruvate kinase, myokinase, acyl coenzyme A synthetase, ornithine carbamyl transferase,
Examples include creatine kinase, aspartate aminotransferase, alanine aminotransferase, and isomerases such as glutamate racemase, alanine racemase, triosephosphate isomerase, and the like. In addition, when analyzing an enzyme component in a sample as a reagent in the reagent layer 3, a substrate that specifically enzymatically reacts with the above-mentioned enzyme, such as L-aspartic acid, L-alanine, α-
Ketoglutaric acid, pyruvic acid, L-lactic acid, L-
Leucinamide, glucose-6-phosphate, starch, acetylcholine, creatine, glutathione, ethanolamine, β-hydroxybutyric acid, ornithine, fructose bisphosphate, triglyceride, phosphoenolpyruvate, isocitric acid, malic acid, plasminogen , dopamine, ascorbic acid, protein, polynucleotide and the like.
ãŸããåèšé
µçŽ ãå«æãã埮çç©ãšããŠãããš
ãã°ã倧è
žèãæ¯èèãã·ãŠãŒãã¢ãã¹ã»ãã¬ã
ãã¯ããªãŠã ãã³ãªããã¯ããªãŠã ã»ã»ã©ãã¢ã
ãµãã«ããã»ã¹ã»ãã³ãŒãã©ãã¯ãªããã³ãã©
ã¹ã»ãã€ã³ãã€ããã¢ã¹ãã«ã®ã«ã¹ã»ããã·ãªãŠ
ã ãã ã³ãŒã«ããªãŸãã¹ãã¹ãã¬ãããã»ã¹ãã¢
ã¯ãããã»ã¹çãæããããã In addition, examples of microorganisms containing the enzyme include Escherichia coli, Bacillus subtilis, Pseudomonas brevibacterium, Corynebacterium serratia,
Examples include Satucharomyces hansenula, Cryptocotrus canida, Aspergillus penicillium, Mucor, Rhizopus, Streptomyces, Actinomyces, and the like.
è©Šè¬å±€ïŒã®èª¿è£œã«éããæ
äœãžã®é
µçŽ ã®åºå®å
æ³åã¯å
æ¬æ³ã¯åžžæ³ã«åŸã€ãŠè¡ãªãã°ããããåº
å®åé
µçŽ ãïŒåçäžéç·šãè¬è«ç€Ÿã1975ïŒã¡ãœ
ãºã»ã€ã³ã»ãšã³ã¶ã€ã¢ããžãŒVol.34ïŒW.B.ãžã€ã³
ããŒãç·šãã¢ã«ãããã¯ãã¬ã¹1974ïŒçã®ææžã«
åèšåžžæ³ãèšèŒãããŠãããé
µçŽ ãã¬ã©ã¹ããŒ
ãºãã»ã«ããŒã¹çã®äžæº¶æ§æ
äœã«çµåãããå Žå
ã«ã¯ãåºå®åé
µçŽ ãåå¿ãŠãããåºæ¿ã®äžã«èœç
ãæ§ã«é©åœãªãã€ã³ããŒåã¯ã²ã«çãçšããã®ã
æãŸããã In preparing the reagent layer 3, the enzyme may be immobilized on the carrier or encased in a conventional manner. The above conventional method is described in books such as "Immobilized Enzymes" (edited by Ichiro Chibata, Kodansha, 1975) and Methods in Enzymology Vol. 34 (edited by WB Jacoby et al., Academic Press 1974). When the enzyme is bound to an insoluble carrier such as glass beads or cellulose, it is desirable to use a suitable binder or gel so that the immobilized enzyme settles on the reaction unit substrate.
å±éå±€ïŒã¯ãå±éå±€ïŒã®äžé¢ã«æ»Žäžããè©Šæã
è©Šè¬å±€ïŒã«åäžãªæ¿åºŠã§ç§»éããããšãã§ããã
ãã«è©Šæãæ¡æ£ããããã®ã§ãã€ãŠãããšãã°å
èšè©Šè¬å±€ïŒã®åœ¢æã«çšããåçš®ã®ã²ã«ã䜿çšãã
ããšãã§ããããã®æ§ãªã²ã«ãè©Šè¬å±€äžã«éç³ã
ãããšã«ãã€ãŠã滎äžãããè©Šæãè©Šè¬å±€ã®åºã
ãæ¹åãžãæ¡æ£ãããã®ã§ãè©Šæãè©Šè¬å±€å
šäœã«
åäžãªæ¿åºŠã§ç§»éããããšãã§ããã The spreading layer 1 diffuses the sample so that the sample dropped on the upper surface of the spreading layer 1 can be transferred to the reagent layer 3 at a uniform concentration. gel can be used. By superimposing such a gel on the reagent layer, the dropped sample is also diffused in the direction in which the reagent layer spreads, so that the sample can be transferred to the entire reagent layer at a uniform concentration.
é»æ¥µéšïŒãšããŠã¯ãé»æ°ååŠçæ段ãæ¡çšãã
ããšãã§ããããšãã°è©Šè¬å±€ïŒäžã§ã®åå¿çæç©
ãã€ãªã³ã§ãããšãã«ã¯ã€ãªã³é»æ¥µããåå¿çæ
ç©ãéé
žåæ°ŽçŽ ã§ãããšãã«ã¯éé
žåæ°ŽçŽ é»æ¥µã
çšããããšãã§ããã Electrochemical means can be used as the electrode part 6, for example, an ion electrode is used when the reaction product in the reagent layer 3 is an ion, and a hydrogen peroxide electrode is used when the reaction product is hydrogen peroxide. can be used.
ãªãã第ïŒå³ã«ç€ºãæ€äœæ€æ»ãŠãããã¯äžå®æœ
äŸè£
眮ã§ãã€ãŠããã®çºæã®èŠæšã®ç¯å²å
ã§é©å®
ã«å€åœ¢ããããšãã§ããã The specimen testing unit shown in FIG. 1 is one embodiment of the apparatus, and may be modified as appropriate within the scope of the invention.
ããšãã°ã第ïŒå³ã«ç€ºãé»æ¥µéšïŒã®ãããã«ã
第ïŒå³ïŒ¡ããã³ïŒ¢ã«ç€ºãããã«ãåå¿ãŠãããåº
æ¿ïŒäžã«äžå¯Ÿã®é»æ¥µïŒïŒãé
眮ãããšå
±ã«ãé»æ¥µ
ïŒïŒãšåå¿ãŠãããåºæ¿ïŒã®ç«¯éšã«èšããæ¥ç¶éš
ïŒïŒãšããªãŒãç·ïŒïŒã§é»æ°çã«æ¥ç¶ããåèšå
å¿ãŠãããåºæ¿ïŒäžã«è©Šè¬å±€ïŒã圢æããããšã«
ããé»æ¥µïŒïŒãè©Šè¬å±€ïŒäžã«åèšããããã«æ€åº
æ段ãæ§æããŠãããã For example, instead of the electrode section 6 shown in FIG.
As shown in FIGS. 2A and 2B, a pair of electrodes 11 are arranged on the reaction unit substrate 4, and the electrodes 11 and the connection part 13 provided at the end of the reaction unit substrate 4 are electrically connected using a lead wire 12. The detection means may be configured such that the electrode 11 is embedded in the reagent layer 3 by connecting it to the reaction unit substrate 4 and forming the reagent layer 3 on the reaction unit substrate 4.
以äžæ§æã®æ€äœæ€æ»ãŠãããïŒç¬¬ïŒå³ã«ç€ºãè£
眮ïŒã䜿çšãããšæ¬¡ã®ããã«ããŠè©Šæäžã®åºè³ªæ
åãŸãã¯é
µçŽ æåãåæããããšãã§ããã Using the sample testing unit (the apparatus shown in FIG. 1) configured as described above, the substrate component or enzyme component in a sample can be analyzed in the following manner.
å
ããå±éå±€ïŒã®è¡šé¢ã«è©Šæããšãã°è¡æ¶²è©Šæ
ã滎äžãããšãè¡æ¶²è©Šæã¯å±éå±€ïŒäžã§æ¡æ£ããŠ
åäžãªæ¿åºŠãšãªã€ãŠè©Šè¬å±€ïŒã«å°éãããå°é
åŸãè¡æ¶²è©Šæäžã®åºè³ªæåïŒãŸãã¯é
µçŽ æåïŒãš
è©Šè¬å±€ïŒäžã«ä¿æãããŠããé
µçŽ ïŒãŸãã¯åºè³ªïŒ
ãšãç¹ç°çãªé
µçŽ åå¿ãæ¹èµ·ããããããããšã
é
µçŽ åå¿ã«ããåå¿çæç©ãçæãããã®åå¿ç
æç©ãé»æ¥µéšïŒã«ããé»æ°ååŠçã«å®éããããš
ã«ããè¡æ¶²è©Šæäžã®åºè³ªæåïŒãŸãã¯é
µçŽ æåïŒ
ãå®éããããšãã§ããã First, when a sample, such as a blood sample, is dropped onto the surface of the developing layer 1, the blood sample diffuses in the developing layer 1 and reaches the reagent layer 3 with a uniform concentration. After reaching the substrate component (or enzyme component) in the blood sample and the enzyme (or substrate) retained in the reagent layer 3
triggers a specific enzymatic reaction. Then,
A reaction product is produced by the enzymatic reaction, and the reaction product is electrochemically quantified by the electrode unit 6 to determine the substrate component (or enzyme component) in the blood sample.
can be quantified.
次ã«ãè©Šæäžã®æåãŸãã¯æäœãåèšæ€äœæ€æ»
ãŠãããã§åæããå Žåã«ã€ããŠè¿°ã¹ãã Next, a case will be described in which an antigen or antibody in a sample is analyzed by the sample testing unit.
è©Šè¬å±€ïŒäžã®æ
äœã¯ãè©Šæäžã®åºè³ªæåãŸãã¯
é
µçŽ æåãåèšæ€äœæ€æ»ãŠãããã§åæããå Žå
ãšåãæ
äœã䜿çšããããšãã§ããã The carrier in the reagent layer 3 can be the same carrier used when the substrate component or enzyme component in the sample is analyzed by the sample testing unit.
è©Šè¬å±€ïŒã«ãããè©Šè¬ãšããŠã¯ãè©Šæäžã®æå
ïŒãŸãã¯æäœïŒãåæããå Žåãè£äœæŽ»æ§ã«ãã
现è溶解äœçšãåãã现èèã«æäœïŒãŸãã¯æ
åïŒçµåãããšå
±ã«å
éšã«é
µçŽ ïŒãŸãã¯åºè³ªïŒã
å容ãããã€ã¯ãã«ãã»ã«ããã³ãã€ã¯ãã«ãã»
ã«å
ã«å容ãããé
µçŽ ïŒãŸãã¯åºè³ªïŒãšç¹ç°çã«
åå¿ããåºè³ªïŒãŸãã¯é
µçŽ ïŒãå«æããå
ç«åæ
çšè©Šè¬ãæããããã When analyzing an antigen (or antibody) in a sample, the reagent in the reagent layer 3 binds the antibody (or antigen) to the cell membrane, which undergoes cytolytic action due to complement activation, and accommodates the enzyme (or substrate) inside. Examples thereof include microcapsules and immunoassay reagents containing a substrate (or enzyme) that specifically reacts with the enzyme (or substrate) contained within the microcapsules.
æäœïŒãŸãã¯æåïŒãçµåãé
µçŽ ïŒãŸãã¯åº
質ïŒãå容ããããšã®ã§ãããã€ã¯ãã«ãã»ã«ãš
ããŠã¯ãåç©ããšãã°çŸã®èµ€è¡çã奜é©ã«çšãã
ããšãã§ããããªããä»ã®åç©ã®èµ€è¡çãããã¯
èµ€è¡ç以å€ã®åç©çŽ°èã§ãã€ãŠãã现èèã«æäœ
ïŒãŸãã¯æåïŒãçµåãããŸãã现èå
ã«é
µçŽ
ïŒãŸãã¯åºè³ªïŒãå容ããããšãã§ããã°ããã®
çºæã«ããããã€ã¯ãã«ãã»ã«ãšããŠäœ¿çšããã
ãšãã§ããããŸããããã«ã人工èãšããŠãªããœ
ãŒã ã䜿çšããããšãã§ããã As microcapsules capable of binding antibodies (or antigens) and accommodating enzymes (or substrates), red blood cells of animals such as sheep can be suitably used. Note that even if red blood cells of other animals or animal cells other than red blood cells can be used as microorganisms in this invention, as long as they can bind antibodies (or antigens) to the cell membrane and contain enzymes (or substrates) within the cells. Can be used as capsules. Furthermore, liposomes can also be used as artificial membranes.
现èèã«çµåããæäœïŒãŸãã¯æåïŒã¯ãè©Šæ
äžã®æåïŒãŸãã¯æäœïŒãšç¹ç°çãªæåæäœåå¿
ãæ¹èµ·ãããã®ãé©å®ã«éžã°ãããããšãã°ãè©Š
æäžã®æåãαâããšããããã€ã³ã§ãããšã
ã¯ãαâããšããããã€ã³æäœãæããããã The antibody (or antigen) that binds to the cell membrane is appropriately selected to induce a specific antigen-antibody reaction with the antigen (or antibody) in the sample. For example, when the antigen in the sample is α-fetoprotein, an α-fetoprotein antibody can be used.
ãŸãã现èå
ã«å容ããé
µçŽ ã¯ãããšãã°åèš
ãããããªé
žåéå
é
µçŽ ãå æ°Žå解é
µçŽ ã転移é
µ
çŽ ãç°æ§åé
µçŽ ããããã¯åèšåçš®ã®é
µçŽ ãæ··å
ãããã®ãæããããã现èå
ã«åèšé
µçŽ ãå容
ãããããã«åèšããåçš®ã®é
µçŽ ãšç¹ç°çã«åå¿
ããåºè³ªãå容ããŠãããããã ãã现èå
ã«å
容ããåºè³ªã¯ã现èèãééãã«ããç©è³ªã§ãã
ã®ã奜ãŸãããããšãã°çŽ°èãèµ€è¡çããªããœãŒ
ã çã§ãããšãã«ã¯å¡©çŽ ã€ãªã³ãã°ãªã»ããŒã«ã
çæ°Žæ§ç©è³ªããšãã°ãªã³è質ãèµ€è¡çèã®èœå茞
éã§ééå¯èœãªç©è³ªããšãã°ã°ã«ã³ãŒã¹ãã¢ãã
é
žãæããããã Further, examples of enzymes to be accommodated in the cells include the above-mentioned oxidoreductases, hydrolases, transferases, isomerases, and mixtures of the various enzymes mentioned above. Instead of accommodating the enzymes in the cells, a substrate that specifically reacts with the various enzymes described above may be accommodated. However, it is preferable that the substrate accommodated in the cell be a substance that does not easily permeate the cell membrane; for example, when the cell is a red blood cell, liposome, etc., chloride ions, glycerol, etc.
Examples include hydrophobic substances such as phospholipids, substances that can be permeated by active transport through the red blood cell membrane such as glucose, and amino acids.
ãã€ã¯ãã«ãã»ã«å
ã«å容ããé
µçŽ ïŒåã¯åº
質ïŒã®éã¯ããã€ã¯ãã«ãã»ã«èª¿è£œæã«èªç±ã«èª¿
æŽå¯èœã§ããïŒåæ²¢æºïŒçååŠ53(9)ã1066
ïŒ1981ïŒïŒãåŸã€ãŠæž¬å®å¯Ÿè±¡ã®æåïŒåã¯æäœïŒã®
æ¿åºŠç¯å²ã«å¿ããŠããã€ã¯ãã«ãã»ã«å
ã«å容ã
ãé
µçŽ åã¯åºè³ªã®æ¿åºŠãé©å®ã«èª¿æŽããäºãåºæ¥
ããéåžžãæäœïŒãŸãã¯æåïŒéã«å¯ŸããŠçŽ°èå
ã®é
µçŽ ïŒãŸãã¯åºè³ªïŒéã倧éå°ã§ããã®ã§ãã
ã®çºæã®æ€äœæ€æ»ãŠããããçšããå
ç«åæ枬å®
ãçæéã®ãã¡ã«è¡ãªãããšãã§ããã The amount of enzyme (or substrate) accommodated in microcapsules can be freely adjusted during microcapsule preparation (Mitsuru Yoshizawa: Biochemistry 53 (9), 1066
(1981)). Therefore, the concentration of the enzyme or substrate contained in the microcapsules can be adjusted as appropriate depending on the concentration range of the antigen (or antibody) to be measured. Since the amount of intracellular enzyme (or substrate) is usually in large excess of the amount of antibody (or antigen), immunoassay measurements using the sample testing unit of the present invention can be carried out in a short period of time.
现èããšãã°çŸã®èµ€è¡çã®çŽ°èèã«æäœããšã
ã°Î±âããšããããã€ã³æäœãçµåããèµ€è¡çå
ã«é
µçŽ ããšãã°ã°ã«ã³ãŒã¹ãªãã·ã¿ãŒãŒãåçŽã
ã现èã®èª¿è£œã¯ãããšãã°æ¬¡ã®ããã«ããŠè¡ãªã
ããšãã§ããã Cells, such as sheep red blood cells, in which an antibody such as an α-fetoprotein antibody is bound to the cell membrane and an enzyme such as glucose oxidase is housed within the red blood cells can be prepared, for example, as follows.
å
ããåç©ããšãã°ãŠãµã®ãã€ã®ãããŠã¹ãã©
ããçã«Î±âããšããããã€ã³ãåžžæ³ã«åŸã€ãŠæ³š
å°ãããšããããåç©ã¯æäœãããŠåç©äœå
ã§Î±
âããšããããã€ã³æäœãç£çãããã泚å°åŸé©
åœãªæéã®çµéåŸããã®åç©ããæå®éã®è¡æ¶²ã
æ¡åããåŸãããè¡æ¶²ã®äžæŸã¿æ¶²ãåé¢ããããš
ã«ãããαâããšããããã€ã³æäœãæããæè¡
æž
ãåŸãããªããæåæäœåå¿ã®ç¹ç°æ§ãåäžã
ããããã«ãåèšæè¡æž
ãããã«ç²Ÿè£œããŠãã
ããäžæ¹ãä»ã®åç©ããšãã°ãããžããæå®éã®
è¡æ¶²ãæ¡åããŠããã粟補ããç匵液ããšãã°
0.15Mã®æ¿åºŠã®å¡©ãå«æãããããã¢æ¶²ïŒPHïŒïŒ
ãšæ··åããããšã«ããèµ€è¡çããµã¹ãã³ãããç
匵液ãåŸãããã®ç匵液äžã«ãµã¹ãã³ãããèµ€è¡
çäžã«ã¯çŽ°è液ãããã³ã³ããªã¢çãå«ãŸããŠã
ãã®ã§ãåžžæ³ã§ãããéææ³ã«ãã€ãŠèµ€è¡çå
ã
ã现è液çãæåºããŠèµ€è¡çå
ã«é
žçŽ ã§ããã°ã«
ã³ã¢ãã©ãŒãŒãå容ãããå容ããã°ã«ã³ã¢ãã©
ãŒãŒã®éã¯ãåŸè¿°ããå
ç«åæ枬å®æ³ã®å¿
èŠã«å¿
ããŠé©å®ã«æ±ºå®ããããšãã§ããã次ãã§ããã
ãžã®èµ€è¡çããµã¹ãã³ãããç匵液ãšåèšã®Î±â
ããšããããã€ã³æäœãæããæè¡æž
ãšãæ··åã
ããšããããžã®èµ€è¡çã®çŽ°èèäžã«Î±âããšãã
ããã€ã³æäœãåžçãããαâããšããããã€ã³
æäœã现èèã«çµåããèµ€è¡çãæããç匵液ã
åŸãããããã®å Žåãèµ€è¡çèãæäœãåžçãã«
ããæã¯ãã°ã«ã¿ã«ã¢ã«ããããç¡æ°Žã³ãã¯é
žã®
æ§ãªïŒäŸ¡æ§è©Šè¬ããŠããã¯ãŒãè©Šè¬ã®æ§ãªããã
ãè©Šè¬çãšå
±ã«åŠçããäºã«ãããèè¡šé¢ã«æå
ïŒåã¯æäœïŒãçµåãããäºãã§ããã First, when α-fetoprotein is injected into animals such as rabbits, goats, mice, rats, etc. in a conventional manner, these animals become sensitized and produce α-fetoprotein in their bodies.
- Fetoprotein antibodies are produced. After an appropriate period of time has elapsed after the injection, a predetermined amount of blood is collected from the animal, and the supernatant of the blood is separated to obtain antiserum containing α-fetoprotein antibodies. Note that the antiserum may be further purified in order to improve the specificity of the antigen-antibody reaction. On the other hand, a predetermined amount of blood is collected from another animal, such as a sheep, and purified, and an isotonic solution, such as a sheep, is purified.
Buffer solution containing salt at a concentration of 0.15M (PH7)
An isotonic solution in which red blood cells are suspended is obtained by mixing with Since the red blood cells suspended in this isotonic solution contain cell fluid, mitochondria, etc., the cell fluid, etc. are expelled from the red blood cells using the standard dialysis method, and oxygen is returned to the red blood cells. Contains glucoamylase. The amount of glucoamylase to be accommodated can be appropriately determined depending on the needs of the immunoassay method described below. Next, an isotonic solution in which sheep red blood cells were suspended and the above α-
When mixed with an antiserum containing fetoprotein antibodies, the α-fetoprotein antibodies are adsorbed onto the cell membranes of sheep red blood cells, resulting in an isotonic solution with the red blood cells binding the α-fetoprotein antibodies to the cell membranes. . In this case, if the red blood cell membrane has difficulty adsorbing antibodies, antigens (or antibodies) can be attached to the membrane surface by treatment with a divalent reagent such as glutaraldehyde or succinic anhydride, or a peptide reagent such as Udward's reagent. can be combined.
åèšå
ç«åæçšè©Šè¬äžã«ãåèšçŽ°èãšå
±åãã
ãåºè³ªïŒãŸãã¯é
µçŽ ïŒã¯ãåèšçŽ°èäžã«å容ãã
ãé
µçŽ ïŒãŸãã¯åºè³ªïŒãšç¹ç°çã«é
µçŽ åå¿ããã
åè¿°ã®åºè³ªïŒãŸãã¯é
µçŽ ïŒã䜿çšããããšãã§ã
ãã The substrate (or enzyme) coexisting with the cells in the immunoassay reagent is the aforementioned substrate (or enzyme) that specifically enzymatically reacts with the enzyme (or substrate) accommodated in the cells. be able to.
è©Šè¬å±€ïŒã®èª¿è£œãšããŠãããšãã°å
ç«æž¬å®æ³ã§
éåžžè¡ãªããããå¯å€©ã²ã«ã䜿çšããæ¹æ³ã§ãã€
ã¯ãã«ãã»ã«ãå
æ¬ããããšãã§ãããåèšæ¹æ³
ã¯ãå
ç«ååŠå®éšå
¥éïŒæŸæ©çŽãèãåŠäŒåºçã»
ã³ã¿ãŒïŒ1981ïŒïŒãèšåºãšãŠã€ã«ã¹ïŒïŒå·»ã479é
ïŒ1981ïŒãäœè€åŸä¹ãïŒã«è©³çŽ°ã«èšèŒãããŠããã To prepare the reagent layer 3, microcapsules can be encapsulated, for example, by a method using agar gel, which is commonly carried out in immunoassays. The method is described in detail in Introduction to Immunochemistry Experiments (Nao Matsuhashi et al., Gakkai Publishing Center (1981)) and Clinical Practice and Virology (Vol. 9, p. 479 (1981), Seiya Sato et al.).
å±éå±€ïŒã¯ãè©Šæäžã®åºè³ªæåãŸãã¯é
µçŽ æå
ãåèšæ€äœæ€æ»ãŠãããã§åæããå Žåãšåãå±
éå±€ã䜿çšããããšãã§ããã As the developing layer 1, it is possible to use the same developing layer that is used when the substrate component or enzyme component in the sample is analyzed by the sample testing unit.
ãªãã现èèã溶解ããè£äœã¯ãåç©ã®è¡æ¶²äž
ã«å«ãŸããŠãããã®ã䜿çšããããšãã§ããããš
ãã°ã¢ã«ã¢ããã®è¡æž
ãè£äœå«æ液ãšããŠãã®ãŸ
ãŸäœ¿çšããããšãã§ããããŸããè£äœã¯ãããã
ããåèšè©Šè¬å±€ïŒãå±éå±€ïŒã®ããããã«æ·»å ã
ãŠãããŠããããäºæ¬¡è©Šè¬ãšããŠåŸã«æ·»å ããŠã
ããã Note that the complement that dissolves cell membranes can be one that is contained in the blood of an animal; for example, guinea pig serum can be used as it is as a complement-containing liquid. Further, the complement may be added to either the reagent layer 3 or the developing layer 1 in advance, or may be added later as a secondary reagent.
é»æ¥µéšïŒãšããŠã¯ãè©Šæäžã®åºè³ªæåãŸãã¯é
µ
çŽ æåãåèšæ€äœæ€æ»ãŠãããã§åæããå Žåãš
åæ§ã®é»æ¥µã䜿çšããããšãã§ããã As the electrode section 6, the same electrode as used when analyzing the substrate component or enzyme component in the sample with the sample testing unit can be used.
以äžæ§æã®æ€äœæ€æ»ãŠãããã䜿çšãããšæ¬¡ã®
ããã«ããŠè©Šæäžã®æåïŒãŸãã¯æäœïŒãå®éã
ãããšãã§ããã When the sample testing unit having the above configuration is used, antigens (or antibodies) in a sample can be quantified in the following manner.
å
ããå±éå±€ïŒã®è¡šé¢ã«è©Šæããšãã°è¡æ¶²è©Šæ
ã滎äžãããšãè¡æ¶²è©Šæã¯å±éå±€ïŒäžã§æ¡æ£ããŠ
åäžãªæ¿åºŠãšãªã€ãŠè©Šè¬å±€ïŒã«å°éãããå°é
åŸãè¡æ¶²è©Šæäžã®æåïŒãŸãã¯æäœïŒãšè©Šè¬å±€ïŒ
äžã«ä¿æãããŠãã现èã®èè¡šé¢ã«çµåãããŠã
ãæäœïŒãŸãã¯æåïŒãšãç¹ç°çãªæåæäœåå¿
ãæ¹èµ·ããããããããšãå±éå±€ïŒããè¡æ¶²è©Šæ
ãšå
±ã«ç§»éãããŠããããããã¯è©Šè¬å±€ïŒäžã«å
ããããŠããè£äœããåèšæåæäœåå¿ã«ãã掻
æ§åãããè£äœæŽ»æ§ã«ãã现è溶解äœçšã«ãã现
èèã溶解ããŠçŽ°èå
ã«å容ãããŠããé
µçŽ ïŒãŸ
ãã¯åºè³ªïŒã现èå€ã«æŸåºããããæŸåºãããé
µ
çŽ ïŒãŸãã¯åºè³ªïŒãšè©Šè¬äžã®åºè³ªïŒãŸãã¯é
µçŽ ïŒ
ãšãè©Šè¬å±€ïŒäžã§é
µçŽ åå¿ããåå¿çæç©ãåŸã
ããã次ãã§ããã®åå¿çæç©ãé»æ¥µéšïŒã«ãã
é»æ°ååŠçã«å®éããããšãã§ããããªããè¡æ¶²
è©ŠæãšããŠã¯ãè¡æž
ãè¡æŒ¿ããã®ä»å
šè¡ã§ãã€ãŠ
ãããã First, when a sample, such as a blood sample, is dropped onto the surface of the developing layer 1, the blood sample diffuses in the developing layer 1 and reaches the reagent layer 3 with a uniform concentration. After reaching the antigen (or antibody) in the blood sample and reagent layer 3
Antibodies (or antigens) bound to the membrane surface of cells retained in the membrane induce a specific antigen-antibody reaction. Then, the complement that has been transferred with the blood sample from the spreading layer 1 or added to the reagent layer 3 is activated by the antigen-antibody reaction, and the cell membrane is dissolved by the cytolytic action of complement activity. The enzyme (or substrate) contained within the cell is released outside the cell. Enzyme (or substrate) released and substrate (or enzyme) in reagent
undergoes an enzymatic reaction in the reagent layer 3 to obtain a reaction product. Next, this reaction product can be electrochemically quantified using the electrode section 6. Note that the blood sample may be serum, plasma, or other whole blood.
以äžã®å®æœäŸã«ãããã®çºæã«ã€ããŠããã«è©³
è¿°ããã The following examples further illustrate this invention.
å®éšäŸ ïŒ
ãã®å®éšäŸã¯ããã®çºæã®æ€äœæ€æ»ãŠãããã
çšããŠè¡æ¶²è©Šæäžã®ã°ã«ã³ãŒã¹ïŒåºè³ªæåïŒãå®
éãããã®ã§ãããExperimental Example 1 In this experimental example, glucose (substrate component) in a blood sample is quantified using the sample testing unit of the present invention.
ã¢ã¬ããŒã¹ïŒ22mgïŒmlïŒããã³ã¢ã¹ãã«ã®ã«ã¹
ç±æ¥ã®ã°ã«ã³ãŒã¹ãªãã·ããŒãŒïŒ40ÎŒïœïŒmlïŒã
å«æãã0.1Mãªã³é
žãããã¢ãŒïŒPH6.5ïŒããã©
ã¹ããã¯è£œã®åå¿ãŠãããåºæ¿äžã«å¹³æ»ã«æµå»¶
ããå·åŽåºåããããšã«ããè©Šè¬å±€ã圢æããã
次ãã§ããã®è©Šè¬å±€äžã«ãããã«ãã¢ã¬ããŒã¹
ïŒ22mgïŒmlïŒãå«æãã0.1Mãªã³é
žãããã¢ãŒ
ïŒPH6.5ïŒãéå±€ããåºåããããšã«ããå±éå±€ã
圢æããããã®å Žåãåå¿ãŠãããåºæ¿ã«ã¯æå®
ã®å€§ããã®é»æ¥µæ¿å
¥åãéå£ããŠãããåå¿ãŠã
ããåºæ¿äžã«ã¯èãããªå¡©åããã«ã®èã貌çã
ããŠããŠãè©Šè¬å±€ã®åœ¢æã®éã«é»æ¥µæ¿å
¥åãããª
ã³é
žãããã¢ãŒãæŒåºããªãããã«ãªã€ãŠããã
é»æ¥µæ¿å
¥åã«ã¯é»æ¥µéšãåµè£
ãããè©Šè¬å±€äžã«é»
極ããã蟌ãŸããŠããã次ã«ãå±éå±€äžã«çŽ10ÎŒ
ã®è¡æž
ã滎äžãããè¡æž
ã¯å±éå±€äžãæ¡æ£ãã
äžå®ã®æ¿åºŠãšãªã€ãŠè©Šè¬å±€ã«ç§»è¡ããè©Šè¬å±€ã«ã
ããŠä»¥äžã®é
µçŽ åå¿ãé²è¡ããã By smoothly casting 0.1 M phosphate buffer (PH6.5) containing agarose (22 mg/ml) and Aspergillus-derived glucose oxidase (40 ÎŒg/ml) onto a plastic reaction unit substrate, and solidifying by cooling. A reagent layer was formed.
Next, 0.1 M phosphate buffer (PH6.5) containing agarose (22 mg/ml) was further layered on this reagent layer and solidified to form a spreading layer. In this case, the reaction unit substrate has an electrode insertion hole of a predetermined size, and a thin polyvinyl chloride film is pasted on the reaction unit substrate, and the electrode is inserted during the formation of the reagent layer. The pores are designed to prevent phosphate buffer from leaking out.
An electrode part is fitted into the electrode insertion hole, and the electrode is inserted into the reagent layer. Next, place about 10Ό on the spreading layer.
serum was added dropwise. The serum diffuses through the spreading layer,
The concentration reached a certain level and moved to the reagent layer, where the following enzymatic reaction proceeded.
ã°ã«ã³ãŒã¹ïŒO2ïŒH2OGOD
ââââ
ã°ã«ã³ã³é
žïŒH2O2
åå¿ã®çµæè©Šè¬å±€äžã«H2O2ãçæããããã®
H2O2ãé»æ¥µéšã®éé
žåæ°ŽçŽ é»æ¥µã§æ€åºããã Glucose + O 2 + H 2 OGOD ---â Gluconic acid + H 2 O 2 As a result of the reaction, H 2 O 2 was generated in the reagent layer. this
H 2 O 2 was detected using a hydrogen peroxide electrode in the electrode section.
第ïŒå³ã«è¡æž
è©Šæäžã®ã°ã«ã³ãŒã¹æ¿åºŠãšéé
žå
æ°ŽçŽ é»æ¥µããåºåãããé»æµã®å¢å å€ãšã®é¢ä¿ã
瀺ãã第ïŒå³ã«ç€ºãããã«ãè¡æ¶²è©Šæäžã®ã°ã«ã³
ãŒã¹æ¿åºŠãšé»æµå¢å å€ãšã¯çŽç·é¢ä¿ãæç«ããé
é
žåæ°ŽçŽ é»æ¥µã«ãã枬å®ã§è¡æ¶²è©Šæäžã®ã°ã«ã³ãŒ
ã¹ãå®éããããšãã§ããããšãæããã§ããã
ãŸããåäžã®è¡æ¶²è©ŠæãçšããŠã°ã«ã³ãŒã¹ãå®é
ãããã®å®éçµæã第ïŒè¡šã«ç€ºãã第ïŒè¡šã«ç€ºã
ããã«ããã®æ€äœæ€æ»ãŠãããã«ããå®éã¯ãã
ãããŠé«ã粟床ããã€ãŠè¡ãªãããšãã§ããã FIG. 3 shows the relationship between the glucose concentration in the serum sample and the increase in the current output from the hydrogen peroxide electrode. As shown in FIG. 3, there is a linear relationship between the glucose concentration in the blood sample and the current increase value, and it is clear that the glucose in the blood sample can be quantified by measurement using a hydrogen peroxide electrode.
In addition, glucose was quantified using the same blood sample, and the quantification results are shown in Table 1. As shown in Table 1, quantitative determination using this sample testing unit can be performed with extremely high accuracy.
第ïŒè¡š
ã°ã«ã³ãŒã¹ 100mgïŒdl 250mgïŒdl
枬å®ïŒ 0.042 0.056
ïŒ 0.038 0.053
ïŒ 0.039 0.055
ïŒ 0.042 0.054
ïŒ 0.041 0.055
0.0403 0.0546
S.D. ±0.00179 0.00101
C.V.ïŒïŒ
ïŒ 4.43 1.86
å®éšäŸ ïŒ
ãã®å®éšäŸã¯ããã®çºæã®æ€äœæ€æ»ãŠãããã
çšããŠè¡æ¶²è©Šæäžã®Î±âããšããããã€ã³ïŒæ
åã以äžãαâFPãšç¥ããããšããããïŒãå®é
ãããã®ã§ããã Table 1 Glucose 100mg/dl 250mg/dl Measurement 1 0.042 0.056 2 0.038 0.053 3 0.039 0.055 4 0.042 0.054 5 0.041 0.055 0.0403 0.0546 SD ±0.00179 0.00101 CV (%) 4.43 1.86 Experimental Example 2 This experimental example uses the specimen of this invention. This test unit is used to quantify α-fetoprotein (antigen, hereinafter sometimes abbreviated as α-FP) in a blood sample.
ã¢ã¬ããŒã¹ïŒ12mgïŒmlïŒãæäœèµ€è¡çïŒ100ÎŒ
ïŒmlïŒ100UïŒmlã®ã°ã«ã³ã¢ãã©ãŒãŒãå容ãã
èè¡šé¢ã«Î±âFPæäœãçµåããããã®ïŒãã°ã«ã³
ãŒã¹ãªãã·ã¿ãŒãŒïŒ40ÎŒïœïŒmlïŒãã¢ãããŒã¹
ïŒ10mgïŒmlïŒãããã³è£äœïŒ200ÎŒïŒmlïŒãå«ã
ãªã³é
žç·©è¡é£å¡©æ°ŽïŒPH6.0ïŒããã©ã¹ããã¯è£œå
å¿ãŠãããåºæ¿äžã«å¹³æ»ã«æµå»¶ããå·åŽåºåãã
äºã«ããè©Šè¬å±€ã圢æããããã®è©Šè¬å±€äžã«ãã
ã«ã¢ã¬ããŒã¹ïŒ20mgïŒmlïŒãå«æãããªã³é
žç·©è¡
é£å¡©æ°ŽïŒPH6.0ïŒãéå±€ããåºåããäºã«ããå±
éå±€ã圢æããããã®å Žåãåå¿ãŠãããåºæ¿ã«
ã¯æå®ã®å€§ããã®é»æ¥µæ¿å
¥åãéå£ããŠãããå
å¿ãŠãããåºæ¿äžã«ã¯èãããªå¡©åããã«ã®èã
貌çãããŠããŠãè©Šè¬å±€ã®åœ¢æã®éã«é»æ¥µæ¿å
¥å
ãããªã³é
žãããã¢ãŒãæŒåºããªãããã«ãªã€ãŠ
ãããé»æ¥µæ¿å
¥åã«ã¯é»æ¥µéšãåµè£
ãããè©Šè¬å±€
äžã«é»æ¥µããã蟌ãŸããŠããã次ã«ãå±éå±€äžã«
çŽ10ÎŒã®è¡æž
ã滎äžããã Agarose (12mg/ml), sensitized red blood cells (100ÎŒ
/ml; Contains 100U/ml glucoamylase,
α-FP antibody bound to the membrane surface), glucose oxidase (40 Όg/ml), amylose (10 mg/ml), and complement (200 Ό/ml) in phosphate buffered saline (PH6.0). A reagent layer was formed by smoothly casting onto a plastic reaction unit substrate and solidifying by cooling. A phosphate buffered saline solution (PH6.0) containing agarose (20 mg/ml) was further layered on this reagent layer and solidified to form a developing layer. In this case, the reaction unit substrate has an electrode insertion hole of a predetermined size, and a thin polyvinyl chloride film is pasted on the reaction unit substrate, and the electrode is inserted during the formation of the reagent layer. The pores are designed to prevent phosphate buffer from leaking out. An electrode part is fitted into the electrode insertion hole, and the electrode is inserted into the reagent layer. Next, approximately 10Ό of serum was dropped onto the developing layer.
次ã«å±éå±€äžã«çŽ10ÎŒã®è¡æž
ãæ·»å ãããè¡
æž
ã¯å±éå±€äžãæ¡æ£ããäžå®ã®æ¿åºŠãšãªã€ãŠãè©Š
è¬å±€ã«ç§»è¡ãè©Šè¬å±€ã«ãããŠæåãæäœåå¿ãé²
è¡ããããã®çµæãè£äœã«ããèãç Žå£ãããè¡
çïŒãã€ã¯ãã«ãã»ã«ïŒå
ã«å容ãããŠããã°ã«
ã³ã¢ãã©ãŒãŒãå€ã«æŒåºããŠãããå€ã«åºãã°ã«
ã³ã¢ãã©ãŒãŒã¯ã¢ãããŒã¹ãåºè³ªãšããŠæ¬¡ã®åå¿
ãé²è¡ããã Next, approximately 10ÎŒ of serum was added onto the spreading layer. The serum diffused through the development layer, reached a constant concentration, and moved to the reagent layer, where antigen and antibody reactions proceeded. As a result, the membrane was destroyed by complement, and the glucoamylase contained within the blood cells (microcapsules) leaked out. The glucoamylase that comes out uses amylose as a substrate for the next reaction.
ã¢ãããŒã¹ã°ã«ã³ã¢ãã©ãŒãŒ
âââââââââ
ã°ã«ã³ãŒã¹
ã°ã«ã³ãŒã¹ïŒO2ïŒH2Oã°ã«ã³ãŒã¹ãªãã·ã¿ãŒãŒ
ââââââââââââ
ã°ã«ã³ã³é
žïŒH2O2
åå¿ã®çµæè©Šè¬å±€äžã«H2O2ãçæããããã®
H2O2ãé»æ¥µéšã®éé
žåæ°ŽçŽ é»æ¥µã§æ€åºãããå
å¿æž©åºŠã¯37âã§ã枬å®æéã¯15åã§ããã Amylose glucoamylaseâââââââââ Glucose Glucose + O 2 + H 2 O Glucose oxidaseâââââââââââ Gluconic acid + H 2 O 2 As a result of the reaction, H 2 O 2 is produced in the reagent layer. was generated. this
H 2 O 2 was detected using a hydrogen peroxide electrode in the electrode section. The reaction temperature was 37°C and the measurement time was 15 minutes.
äºãæ¢ç¥æ¿åºŠã®Î±âFPãå«ãè©Šæãçšãæ€é
ç·ãäœæãããã®æ€éç·ããè¡æ¶²è©Šæäžã®Î±â
FPå«éãç¥ãããšãã§ããã A calibration curve is created in advance using a sample containing α-FP at a known concentration, and the calibration curve is used to calculate α-FP in the blood sample.
You can know the FP content.
åäžã®è¡æ¶²è©ŠæãçšããŠÎ±âFPã®å®éãè¡ãª
ã€ãçµæã第ïŒè¡šã«ç€ºããããããæãããªæ§ã«
ãã®æ€äœæ€æ»ãŠãããã«ããå®éã¯ã極ããŠé«ã
粟床ããã€ãŠè¡ãªãäºãã§ããã Table 2 shows the results of quantifying α-FP using the same blood sample. As is clear from this, quantitative determination using this sample testing unit can be performed with extremely high accuracy.
第ïŒè¡š
αâFP 48ngïŒml 320ngïŒml
枬å®ïŒ 0.025ÎŒAïŒã 0.14ÎŒAïŒmin
ïŒ 0.022 0.13
ïŒ 0.023 0.14
ïŒ 0.026 0.14
ïŒ 0.023 0.15
0.0238 0.14
S.D. ±0.00147 0.00632
CV(%) 6.17 4.51
ãçºæã®å¹æã
ãã®çºæã«ãããšãæ§æã®ç°¡åãªæ€äœæ€æ»ãŠã
ãããæäŸããããšãã§ãããç¹ã«ãè©Šè¬å±€äžã§
é²è¡ããåå¿ã®çæç©ãé»æ°ååŠçæ段ã«ããè©Š
æäžã®æåãå®éããã®ã§ãåŸæ¥ã®ããã«ãæ€äœ
æ€æ»ãŠãããå
ã§ã®çºè²æäœãäžèŠãšãªãã°ãã
ããåå
åŠçæ€åºæ段ã«ãããŠäžå¯æ¬ ã§ãããã
ã¯ã°ã©ãŠã³ãæ¶å»çšã®ç¹å®ã®å±€ãèšããå¿
èŠããª
ããããšãã§ãããããããè©Šè¬å±€äžã«æ
æãã
è©Šè¬ã®çš®é¡ã«å¿ããŠè©Šæäžã®åçš®æåãæ£ç¢ºãã€
è¿
éã«å®éåæããããšãã§ãããããšãã°è©Šè¬
å±€äžã«é
µçŽ ïŒãŸãã¯åºè³ªïŒãä¿æããŠãããšãè©Š
æäžã®åºè³ªæåïŒãŸãã¯é
µçŽ æåïŒãæ£ç¢ºã«å®é
ããããšãã§ããããŸããè©Šè¬å±€äžã«ã现èèã«
æäœïŒãŸãã¯åºè³ªïŒãçµåãããšå
±ã«å
éšã«é
µçŽ
ïŒãŸãã¯åºè³ªïŒãå容ãã现èãå«æããå
ç«å
æçšè©Šè¬ãæ
æããããšãæ°åããæ°10å以å
ã§
è©Šæäžã®æåïŒãŸãã¯æäœïŒãè¿
éã«å®éåæã
ãããšãã§ãããããããã²ã«ã«ãã€ãŠæ§æãã
ãå±éå±€ãè©Šè¬å±€äžã«éç³ããããšã§åŸ®å°ã®è©Šæ
ã§ãè©Šæãè©Šè¬å±€å
šäœã«åäžãªæ¿åºŠã§ç§»éããã
ã®ã§ãè©Šæãç¡é§ã«äœ¿çšããããšãªã枬å®ç²ŸåºŠã
åäžããå®éåæã®è¿
éåãå³ãããšãã§ããã Table 2 α-FP 48ng/ml 320ng/ml Measurement 1 0.025ÎŒA/ã 0.14ÎŒA/min 2 0.022 0.13 3 0.023 0.14 4 0.026 0.14 5 0.023 0.15 0.0238 0.14 SD ±0.00147 0.00632 CV(%) 6.17 4.51 [Effect of invention ] According to the present invention, it is possible to provide a sample testing unit with a simple configuration. In particular, since the components in the sample are quantified using electrochemical means based on the products of the reactions that have progressed in the reagent layer, not only is there no need for color development within the sample testing unit, but there is also a need for spectroscopic analysis. The need for a special layer for background cancellation, which is essential in the detection means, can also be eliminated. Moreover, various components in a sample can be accurately and quickly quantitatively analyzed depending on the type of reagent supported in the reagent layer. For example, if the enzyme (or substrate) is retained in the reagent layer, the substrate component (or enzyme component) in the sample can be accurately quantified. In addition, if the reagent layer carries an immunoassay reagent containing cells that bind antibodies (or substrates) to their cell membranes and contain enzymes (or substrates) inside, it is possible to dissolve the sample within several minutes to several tens of minutes. antigens (or antibodies) can be rapidly and quantitatively analyzed. Moreover, by superimposing the spreading layer made of gel on the reagent layer, even a minute sample can be transferred to the entire reagent layer at a uniform concentration, thereby improving measurement accuracy without wasting the sample. It is possible to improve the performance and speed up quantitative analysis.
第ïŒå³ã¯ãã®çºæã®äžå®æœäŸè£
眮ã瀺ã説æ
å³ã第ïŒå³ïŒ¡ã¯ãã®çºæã®ä»ã®å®æœäŸè£
眮ã瀺ã
æé¢å³ã第ïŒå³ïŒ¢ã¯ãã®çºæã®ä»ã®å®æœäŸè£
眮ã
瀺ãäžé¢å³ãããã³ç¬¬ïŒå³ã¯ãã®çºæã®äžå®æœäŸ
è£
眮ãçšããŠè¡æ¶²è©Šæäžã®ã°ã«ã³ãŒã¹ãå®éãã
å Žåã®ã°ã«ã³ãŒã¹æ¿åºŠãšéé
žåæ°ŽçŽ é»æ¥µããåºå
ãããé»æµã®å¢å å€ãšã®é¢ä¿ã瀺ãã°ã©ãã§ã
ãã
ïŒâŠâŠå±éå±€ãïŒâŠâŠè©Šè¬å±€ãïŒâŠâŠé»æ¥µéšã
FIG. 1 is an explanatory diagram showing one embodiment of the device of the present invention, FIG. 2A is a sectional view showing another embodiment of the device of the invention, and FIG. 2B is a top view showing another embodiment of the device of the invention. 3 and 3 are graphs showing the relationship between the glucose concentration and the increase in the current output from the hydrogen peroxide electrode when glucose in a blood sample is quantified using an apparatus according to an embodiment of the present invention. . 1... Development layer, 3... Reagent layer, 6... Electrode section.
Claims (1)
ãæ§æããããšå ±ã«åèšè©Šè¬å±€äžã«éç³ããè©Šæ
ãåäžãªæ¿åºŠã§æ¡æ£ããŠåèšè©Šè¬å±€ã«ç§»éããå±
éå±€ãšãå±éå±€ããæ¡æ£ããŠããè©Šæãšè©Šè¬å±€äž
ã®è©Šè¬ãšã®åå¿çæç©ãé»æ°ååŠçã«æ€åºããæ€
åºæ段ãšãæããåèšå±éå±€ã«è©Šæã滎äžããã
ãšã«ãã該詊æã®æåãé»æ°ååŠçã«æž¬å®ããæ€
äœæ€æ»ãŠãããã ïŒ åèšè©Šè¬ããé µçŽ ãæããããšãç¹åŸŽãšãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ€äœæ€æ»ãŠãã
ãã ïŒ åèšè©Šè¬ããé µçŽ ãå«æãã埮çç©ãæãã
ããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®
æ€äœæ€æ»ãŠãããã ïŒ åèšè©Šè¬ããè£äœæŽ»æ§ã«ãã溶解äœçšãåã
ãèã«æäœãŸãã¯æåãæãããšå ±ã«å éšã«é µçŽ
ãŸãã¯é µçŽ ãšç¹ç°çã«åå¿ããåºè³ªãå容ããã
ã€ã¯ãã«ãã»ã«ãæããããšãç¹åŸŽãšããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ€äœæ€æ»ãŠãããã[Scope of Claims] 1. A reagent layer in which a reagent is immobilized and held; a spreading layer formed of gel and superimposed on the reagent layer to diffuse a sample at a uniform concentration and transfer it to the reagent layer; It has a detection means that electrochemically detects a reaction product between the sample diffused from the developing layer and the reagent in the reagent layer, and the components of the sample are electrochemically detected by dropping the sample onto the developing layer. A specimen testing unit that measures 2. The sample testing unit according to claim 1, wherein the reagent includes an enzyme. 3. The sample testing unit according to claim 1, wherein the reagent contains a microorganism containing an enzyme. 4. Claim 4, characterized in that the reagent has a microcapsule that has an antibody or an antigen on its membrane that undergoes a lytic action due to complement activity, and contains an enzyme or a substrate that specifically reacts with the enzyme inside. The sample testing unit according to item 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13548782A JPS5926048A (en) | 1982-08-03 | 1982-08-03 | Sample inspection unit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13548782A JPS5926048A (en) | 1982-08-03 | 1982-08-03 | Sample inspection unit |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5926048A JPS5926048A (en) | 1984-02-10 |
JPH0514227B2 true JPH0514227B2 (en) | 1993-02-24 |
Family
ID=15152870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13548782A Granted JPS5926048A (en) | 1982-08-03 | 1982-08-03 | Sample inspection unit |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5926048A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0640087B2 (en) * | 1985-03-19 | 1994-05-25 | æŸäžé»åšç£æ¥æ ªåŒäŒç€Ÿ | Biosensor |
GB8508677D0 (en) * | 1985-04-03 | 1985-05-09 | Genetics Int Inc | Assay for salicylate |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56107154A (en) * | 1979-12-04 | 1981-08-25 | Technicon Instr | Produced articles and enzyme activity measuring method* enzyme reaction control method* analyzer* reactor* automatic electrochemical analyzer* and thin film enzyme measuring sensor |
-
1982
- 1982-08-03 JP JP13548782A patent/JPS5926048A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56107154A (en) * | 1979-12-04 | 1981-08-25 | Technicon Instr | Produced articles and enzyme activity measuring method* enzyme reaction control method* analyzer* reactor* automatic electrochemical analyzer* and thin film enzyme measuring sensor |
Also Published As
Publication number | Publication date |
---|---|
JPS5926048A (en) | 1984-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0525723B1 (en) | Process and device for specific binding assay | |
Blaedel et al. | Kinetic behavior of enzymes immobilized in artificial membranes | |
US5534132A (en) | Electrode and method for the detection of an affinity reaction | |
Senillou et al. | A miniaturized urea sensor based on the integration of both ammonium based urea enzyme field effect transistor and a reference field effect transistor in a single chip | |
EP0121385A1 (en) | Conductimetric bioassay techniques | |
JP2588274B2 (en) | Visual identification of qualitative enzyme assays | |
Stein et al. | Comparison of immobilization methods for the development of an acetylcholinesterase biosensor | |
JPS5921500B2 (en) | Enzyme membrane for oxygen electrode | |
Guilbault et al. | Enzyme electrodes for the determination of 1-phenylalanine | |
JPS62232555A (en) | Oxygen sensor | |
Kauffmann et al. | Enzyme electrode biosensors: theory and applications | |
Kobos | Potentiometric enzyme methods | |
US3896008A (en) | Electrochemical potentiometric method for selectively determining alkaline phosphatase content in aqueous fluids | |
US5147781A (en) | Enzyme electrode and assay for determining LDH5 | |
Gotoh et al. | Micro-FET biosensors using polyvinylbutyral membrane | |
Yao et al. | Onâline amperometric assay of glucose, lâglutamate, and acetylcholine using microdialysis probes and immobilized enzyme reactors | |
JP2788264B2 (en) | Enzyme quantification method and device used for it | |
JPH0514227B2 (en) | ||
US4820634A (en) | Immunoassay method and immunoreactive cell reagent | |
Brown et al. | Potentiometric enzyme channelling immunosensor for proteins | |
Boitieux et al. | A computerised enzyme immunosensor: application for the determination of antigens | |
JPH0332357B2 (en) | ||
JPH0376424B2 (en) | ||
Boitieux et al. | Reversible immobilization of an antibody with a thiol-substituted sorbent: application to enzyme immunoassays | |
Jaffrezic-Renault et al. | Development of new polymeric membranes for ENFETs for biomedical and environmental applications |